Facioscapulohumeral Muscular Dystrophy research hub

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

This study is testing a new medicine called del-brax for people with Facioscapulohumeral Muscular Dystrophy (FSHD). Researchers want to see if it's safe and effective in improving or slowing down the condition. It involves receiving treatment every six weeks for over a year.